UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Anticancer drug Riavax used more in last-stage cancer patients
The number of last-stage cancer patients who received emergency treatments ...
by So Jae-hyeon
|
2018-09-13 15:25
라인
Pharma outlook gloomy amid tax probes, reduced biz days
The pharmaceutical industry in Korea is expected to suffer sales declines i...
by So Jae-hyeon
|
2018-09-13 14:39
라인
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’
The biotech industry is paying close attention to how the recent controvers...
by So Jae-hyeon
|
2018-09-12 14:25
라인
MERS infection affects stock market
Pharmaceuticals and biotech businesses are gathering renewed attention afte...
by So Jae-hyeon
|
2018-09-10 16:25
라인
‘Sky Labs’ wearable heart rhythm tracker effective’
Sky Labs made a presentation on the effect of using a wearable device for c...
by So Jae-hyeon
|
2018-09-05 16:12
라인
Pfizer seeks Yuhan’s help to keep anti-smoking drug rolling
Pfizer has picked Yuhan Corp. as a partner to defense its smoking cessation...
by So Jae-hyeon
|
2018-09-05 11:59
라인
Pharmaceuticals seek niche with drug reformulation
Local pharmaceutical companies are striving to find a niche market by chang...
by So Jae-hyeon
|
2018-09-03 16:49
라인
Will ‘world’s first’ dog dementia treatment work?
A Korean drug company working on a treatment for dementia in dogs said that...
by So Jae-hyeon
|
2018-09-03 15:44
라인
Biotech’s big license-out deals calm concerns about bubble
Korean pharmaceutical and biotech companies have won 1.7 trillion won ($1.5...
by So Jae-hyeon
|
2018-09-03 14:21
라인
‘₩5 trillion Thai market attractive to Korean drugmakers
Korean drugmakers should aggressively seek to tap into Thailand’s pharmaceu...
by So Jae-hyeon
|
2018-08-31 16:27
라인
Global ban on promotional aids adds burden on local drugmakers
Korean pharmaceutical firms are agonizing over the latest code of ethics by...
by So Jae-hyeon
|
2018-08-31 14:35
라인
Pharmaceuticals criticize tougher disclosure rules
Pharmaceutical industry officials are continuing to complain about the fina...
by So Jae-hyeon
|
2018-08-29 12:02
라인
Viagra impotent in competition against generics
Viagra (ingredient: sildenafil), the favored treatment for erectile dysfunc...
by So Jae-hyeon
|
2018-08-28 16:05
라인
Korea’s Botox export to China plummet amid crackdown on smuggling
The poor earnings by botulinum toxin makers Medytox and Hugel have somethin...
by So Jae-hyeon
|
2018-08-17 16:27
라인
Biotech firms grudge over regulator’s plan to toughen disclosure rules
Pharmaceutical and biotech industry officials are expressing discontent ove...
by So Jae-hyeon
|
2018-08-17 11:51
라인
Will Tego Science win reimbursement for diabetic foot ulcer treatment?
Tego Science is seeking to obtain insurance coverage for Kaloderm, a biolog...
by So Jae-hyeon
|
2018-08-16 11:34
라인
Parkinson’s drug Azilect beats market leader Stalevo
A rising star drug in the Parkinson’s disease treatment market defeated the...
by So Jae-hyeon
|
2018-08-13 15:32
라인
[News Focus] Valsartan chaos reveals Korean drugmakers’ weakness
The pharmaceutical industry is having time for self-reflection, admitting t...
by So Jae-hyeon
|
2018-08-13 14:21
라인
Competition heats up among Korean Botox makers to develop ‘kDa’
As the global expansion of domestic botulinum toxin (BTX) products is becom...
by So Jae-hyeon
|
2018-08-08 16:53
라인
Over 36.8 billion won worth of banned valsartan-based drugs sold last year
More than 36.9 billion won worth of banned antihypertensive drugs were pres...
by So Jae-hyeon
|
2018-08-07 15:40
-
1
2
3
4
5
6
7
8
9
10
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top